Background and Objective: From mid February to the end of March, each year ϳ30% of Japanese have Japanese cedar pollinosis. Moreover, 10 -50% of patients with this pollinosis exhibit nasal manifestations in the preseason. These patients have a predominance of neutrophils but not eosinophils in nasal swabs and high carriage of Staphylococcus aureus. We hypothesized that S. aureus or other bacteria and associated neutrophilia were involved in preseasonal symptoms.
I n most parts of Japan, there is large shedding of Japanese cedar pollen (JCP) normally beginning in mid-February and ending in mid-April. More than 30% of Japanese experience JCP pollinosis. [1] [2] [3] During the winter, preseason, 10-50% have nasal symptoms. These patients with neutrophilia in nasal smears had a high carriage rate of nasal Staphylococcus aureus. We hypothesized that neutrophilia induced by S. aureus and/or other bacteria are involved in nasal symptoms in the preseason. We examined the relationship between the degree of neutrophilia and the number of S. aureus and other bacterial colonies in culture and compared symptomatic patients in the preseason (PreSyP) and asymptomatic patients in preseason (PreAsP). The difference in the response of these groups to prophylactic allergy treatment with antihistamines and topical steroid was analyzed.
METHODS

Subjects
This study was conducted from early January to the end of April 2011. One hundred eighty-five patients with seasonal allergic rhinitis sensitized only with JCP were studied. All the patients had symptoms in each JCP season over 3 to 30 years. They were diagnosed as having JCP seasonal allergic rhinitis according to Japanese Guidelines for Allergic Rhinitis 2014. [1] [2] [3] During the pollen season, the patients had typical symptoms and eosinophilia in nasal smears. They had positive results only to JCP with class 2 or higher reactivity, as confirmed by immunoassay for specific immunoglobulin E (IgE) antibodies to JCP, house dust, mites, orchard grass, ragweed, mugwort, and Alternaria. Patients given immunotherapy and patients with respiratory infection were excluded from the study.
The patients were divided into three groups ( Table 1 , Fig. 1 B) : 53 patients had no symptoms (PreAsP group), 60 had one or more symptoms of sneezing, nasal discharge, and/or nasal obstruction in the preseason (PreSyP group), and 72 (symptomatic patients in season [InSyP] group) had nasal symptoms after the beginning of pollen shedding (February 22, 2011) . These studies were approved by the Nippon Medical School Ethics Committee, and all the subjects provided informed consent.
Patients' Symptoms and Severity Grading
Patients who were symptomatic and patients who were symptomatic and who visited the clinic before the JCP season were asked whether they had nasal symptoms consistent with pollinosis. Subjects who answered "no" or "yes" were classified as PreAsP or PreSyP, respectively.
All the subjects were given a detailed symptoms questionnaire at each visit. The amount of JCP dispersal is larger than the dispersal of ragweed, grass, birch, pollen, etc. in North America and Europe, 2, 4 and the symptoms of JCP pollinosis are known to be more severe than pollinosis elsewhere. 4, 5 Thus, many Japanese otorhinolaryngologists and allergists believe that the World Health Organization classification of mild or moderate-severe allergic rhinitis and its impact on asthma is unsuitable for JCP. In this study, the grading of symptoms were identified by using Japanese Guidelines ( 
Treatment
The treatment regimen is presented in Table 4 . The patients in the PreAsP and PreSyP groups who requested prophylactic treatment before the JCP season were given second-generation antihistamines; a leukotriene receptor antagonist; and a local steroid, fluticasone propionate (50 g, each nostril twice daily), 1 to 2 weeks before the JCP season. [10] [11] [12] Patients in the InSyP group started the same treatment the day of their first clinic visit during the season. Analysis of treatment effects was performed on data of patients who returned to the clinic for a second or third visit during the pollen season (February 23 to April 16, 2011) . The severity of symptoms as a cumulative score for 1 week before the clinic visit was evaluated. Data of patients who visited the clinic outside of these dates were excluded from Tables 1 and 4 .
Statistical Analysis
For comparison of patient demographics, a t-test (for age), a 2 test (for sex) and Wilcoxon rank sum test (for anti-IgE class) were used; for the rate of bacteria detection, cell infiltration, symptom severity, and bacterial colony counts, a 2 test and Wilcoxon rank sum test were used. A p value of Ͻ0.05 was considered statistically significant.
RESULTS
Pollen Count
JCP counts in Yokohama near Tokyo in 2011 were done by using the Durham method. 13 The cumulative JCP count/cm 2 reached 8079 JCP count/cm 2 (average, 2323 JCP count/cm 2 ; range, 284-6673 JCP count/cm 2 between 2001 and 2010), an all-time record. The pollen count was 0-3 particles/cm 2 until February 22, 2011, and, thereafter, significant JCP shedding began. Until May 18, 2011, pollen counts were double to triple the normal levels. Counts of JCP and Chamaecryparis obtuse, a member of the Japanese cypress tree family, pollen with cross-reactivity with JCP is shown in Fig. 1 A. 
Patient Backgrounds
There were no significant differences in age or sex among the three groups (Table 1) . Higher levels of IgE were found in the InSyP group than in the PreSyP group (p Ͻ 0.05, Wilcoxon rank sum test), whereas there was no significant difference in the anti-JCP IgE levels between the PreAsP and PreSyP groups ( Table 1 ).
Nasal Swab Cytology on the First Clinic Visit
Nasal swab cytology on the first clinic visit are shown in Fig. 2 . Analyses of cells in the mucous layer of nasal swabs showed that almost half (43%) of the PreAsP group had few cells, whereas only approximately a fourth (22%) of the PreSyP group had few cells (p Ͻ 0.05). Forty-seven percent of the PreSyP group had high degree of neutrophilia (2ϩ to 3ϩ), a significantly higher proportion 
Detection of S. aureus and M. catarrhalis in Nasal Swabs on the First Clinic Visit
Data regarding the detection of S. aureus and M. catarrhalis in nasal swabs on the first clinic visit are presented in Table 5 ). S. aureus was detected in 79% of patients in the PreAsP group, 75% in the PreSyP group, and 53% in the InSyP group. There was no significant difference in the rate of detection between PreAsP and PreSyP groups, but the rate of detection in patients in the InSyP group was significantly lower than in the PreAsP and PreSyP groups (p Ͻ 0.01). Interestingly, in the PreSyP group, M. catarrhalis was detected in 25% of the patients, whereas it was found in only 9% of patients in the PreAsP group, a significant difference (p Ͻ 0.05).
5) Comparison between Asymptomatic and Symptomatic Patients in Degree of Neutrophilia
The degrees of neutrophilia (Ϫ, Ϯ, ϩ, 2ϩ, 3ϩ) in S. aureus and M. catarrhalis positive cases were significantly larger in the PreSyP group than in the PreAsP group (p Ͻ.01) ( Table 6 ). However, there was no significant difference in neutrophilia between asymptomatic and Table 6 ).
The Relationship between Neutrophil Abundance in Nasal Swabs and the Number of Colonies of S. aureus and Other Bacteria
The relationship between neutrophil abundance in nasal swabs and the number of colonies of S. aureus and other bacteria is shown in Fig. 3 . We examined the magnitude of neutrophilia in subgroups with the greatest (ϩ to 3ϩ) and the fewest colonies (no colony or small number colonies groups) of each bacteria. In subgroups of the greatest number of colonies of S. aureus (ϩ to 3ϩ), the magnitude of neutrophilia in the PreSyPs group was statistically higher than in those with the fewest colonies (no colony or small number colonies groups) (p Ͻ 0.05) ( Fig. 3 A) .
In the PreAsP group, there was no significant difference between the magnitude of neutrophilia and S. aureus colony counts. In addition, no significant differences were detected for M. catarrhalis, S. pneumoniae, or S. epidermidis counts, and for neutrophilia. In the PreSyP group with higher neutrophilia scores (2ϩ and 3ϩ), S. aureus colony counts were statistically higher than in the PreSyP group, with no or small numbers of neutrophils (Ϫ to ϩ neutrophils) (p Ͻ 0.01) ( Fig. 3 B) .
Effects of Treatment on Symptom Severity
Effects of treatment on symptom severity are presented in Fig. 4 . To assess the effects of treatment, symptoms were evaluated at the second or third clinic visit. Patients who visited only once (n ϭ 7/53 in the PreAsP group, n ϭ 14/60 in the PreSyP group, and 36/72 in InSyP group) ( Table 4 ) were excluded. Furthermore, we only evaluated patients who self-scored their compliance with the antihistamine, antileukotriene, and nasal steroid medications at 50-100% of the days, i.e., patients who were compliant with recommended medications for Ͻ50% of the days were excluded (Fig. 4) the same compliance in the first part of the season and later in the season were 27 and 36, respectively. Compliance with treatment improved symptoms in the PreSyP group in the first part of the season (p Ͻ 0.05, Wilcoxon rank sum test) but did not have a significant benefit in the late part of the season in comparison with preseasonal symptoms. Moreover, for patients who were compliant, symptom severity in the late part of the season was statistically worse in the PreSyP group than in the PreAsP group (p Ͻ 0.05). As anticipated, for compliant patients in the InSyP group (50-100% of the days), symptom scores improved.
DISCUSSION
The morbidity rate of JCP increased from 16.2% in 1998 to 26.5% in 2008. 1 The major symptoms are nasal and eye itching, sneezing, nasal discharge, and obstruction, with severe attacks. To avoid or minimize symptoms of an attack of JCP, many patients visit the clinic for prophylactic treatment. In 10-50% of these patients, nasal manifestations appear before the beginning of JCP shedding. Many allergists indicate that small amounts of JCP shed before major shedding induces these symptoms. However, Okuda et al. 14 indicated that the amount of pollen in nasal lavage of patients with preseasonal symptoms was low and unlikely to account for symptoms. If this involves IgE-mediated reactions, one would expect to see significant eosinophilia in nasal smears from these subjects. Bernstein 15 stated that cell cytology was not essential to make a correct diagnosis but useful as one of the methods for assessment.
Accordingly, in 2010, both before and in the JCP season, we analyzed nasal smears from patients. 16 In 58% of patients with preseasonal symptoms, neutrophils were the predominant cells in nasal smears and only 9.6% of the patients predominantly had eosinophils. By contrast, in patients with symptoms in season, 58% had eosinophilia and only 11% had prominent neutrophilia. S. aureus in 25 patients (64%), S. epidermidis in 12 (30.7%), M. catarrhalis in 10 (25.6%), S. pneumoniae in 4 (10.2%), and Klebsiella pneumoniae in 4 (10.2%) were detected by culture from nasal swabs of patients in the 39 PreSyP group. Analysis of these data indicated that preseasonal symptoms correlate with neutrophilia associated with S. aureus and other bacteria.
To validate and extend our results, we conducted the 2011 study. We compared the magnitude of neutrophils in nasal swabs of patients in the PreAsP group and in the PreSyP group. Neutrophilia graded as 2ϩ to 3ϩ occurred in 47% of patients in the PreSyP group, significantly greater (p Ͻ 0.01) than the 20% of patients in the PreAsP group (Fig. 2) . However, the detection rates of S. aureus in both groups were similar (79% and 75%, respectively) ( Table 4 ). We also counted mast cells in the nasal swabs because of their importance in allergy. 17, 18 The percentage of Mcϩϳϩϩϩ in patients in the InSyP group was significantly higher than in patients in the PreAsP and PreSyP groups (p Ͻ 0.01). However, there was no significant difference between patients in the PreAsP and PreSyP groups.
Moreover, in patients in the PreSyP group, neutrophilia in patients with the highest colony counts of S. aureus (ϩ to 3ϩ) was statistically higher than in those with the fewest colonies (no colony or small number colonies), (p Ͻ 0.05) ( Fig. 3 A) . In patients in the PreSyP group, the numbers of colonies of S. aureus in those patients with the greatest neutrophilia (2ϩ to 3ϩ) was statistically larger than patients with no or few neutrophils (Ϫ to ϩ) (p Ͻ 0.01) ( Fig. 3 B) . Similar differences were not detected in patients in the PreAsP group. Thus, the number of colonies of S. aureus and the magnitude of neutrophil infiltration into nasal secretions correlated. Local neutrophilia may induce nasal epithelial damage and hypersensitivity ( Fig. 5 A-D) .
S. aureus in the airway is generally considered to be a normal inhabitant. However, there have been reports that S. aureus can be relevant to symptomatology in allergic rhinitis. [19] [20] [21] This bacterium can be found inside nasal epithelial cells, 22 and S. aureus-derived exotoxin B, serine proteases, and hemolysin A can induce interleukin (IL)6 and IL-8 release from airway epithelial cells, [23] [24] [25] can induce local neutrophilia, which leads to epithelial damage. 26, 27 Neutrophil-derived elastase and reactive oxygen species can be involved in epithelial cell damage. 28, 29 Other bacteria, e.g., M. catarrhalis, S. pneumoniae, S. epidermidis, also induce IL-6 or IL-8 from respiratory cells and can damage epithelial cells. [30] [31] [32] M. catarrhalis was also associated with preseasonal symptoms in our study.
Patients in the PreSyP group who were compliant (50-100% of the days) with medications had reduced symptom scores ( Fig. 4 ) early during JCP shedding. However, late in the JCP season, symptom scores in patients in the PreSyP group were not better than in patients in the InSyP group who were compliant with medications. Thus, even if patients in the PreSyP or PreAsP groups were given the same prophylactic treatment and were compliant with medications, patients in the PreSyP group had worse symptoms than patients in the PreAsP group (Fig. 4) .
Two publications identified bacterial colonization and seasonal allergic rhinitis in countries other than Japan. 33, 34 However, they did not specifically postulate that bacterial activity led to nasal epithelial damage. Our results highlighted the potential importance of bacterial colonization in symptomatology of allergic rhinitis, and we postulated that epithelial damage may be a critical element. Our injury model ( Fig. 5 ) was likely to be relevant in allergic rhinitis more generally than solely in JCP, and our contribution should stimulate others to investigate in other countries.
CONCLUSION
In patients with JCP pollinosis, activity and growth of S. aureus or M. catarrhalis was associated with local neutrophilia, which potentially led to epithelial damage, which may cause preseasonal manifestations and a relatively poor response to treatment once JCP exposures are high and prolonged. 
